Dr. Eng on Features of High-Risk CRC


In Partnership With:

Cathy Eng, MD, FACP, FASCO, discusses the features of high-risk colorectal cancer.

Cathy Eng, MD, FACP, FASCO, David H. Johnson Chair in Surgical and Medical Oncology, co-leader, Gastrointestinal (GI) Cancer Research Program, professor of medicine (hematology and oncology), co-director, GI Oncology, vice chair, SWOG GI Committee, and director, VICC Young Adult Cancers Initiative, Vanderbilt-Ingram Cancer Center, discusses the features of high-risk colorectal cancer (CRC).

Patients with CRC who are at a high risk of disease recurrence may have an obstruction or perforation at presentation, Eng says.

Additionally, patients who derive a suboptimal response to lymph node dissection, have positive margins, or have evidence of lymphovascular or pleural invasive disease are considered to be high-risk patients, explains Eng.

Finally, patients with poorly differentiated or signet ring cell histologies are at an innately higher risk of disease recurrence compared with patients with other histologic CRC subtypes, concludes Eng.

Related Videos
Jeremy L. Ramdial, MD, assistant professor, Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
Alexandra Gomez Arteaga, MD, Weill Cornell Medicine/New York-Presbyterian Hospital
Rahul Banerjee, MD, FACP, assistant professor, Clinical Research Division, Fred Hutchinson Cancer Center; assistant professor, Division of Hematology and Oncology, University of Washington
Alice Bertaina, MD, PhD
Jeffery Auletta, MD, The Ohio State University College of Medicine
Betty Hamilton, MD, Cleveland Clinic
Stephanie Lee, MD, MPH, Fred Hutchinson Cancer Center
Chul Kim, MD, MPH
Neil D. Gross, MD, FACS
Dae Won Kim, MD, Gastrointestinal Oncology Program, Moffitt Cancer Center